Study S001897

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT07370922
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: SINGLE
Status: COMPLETED
Enrollment: 80
Start: 2024-11-22
Primary completion: 2025-11-22
Lead sponsor: Ain Shams University
Conditions: Transfusion Dependent Beta Thalassemia
Interventions: DRUG:Dulaglutide 0.75Mg/0.5Ml Inj Pen; DRUG:control group (insulin)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in glycemic variability using continuous glucose monitoring after 6 months. [6 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0001986	Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA). Adly AAM, Diabetologia	2026	Randomized trial	PMID 42618811 DOI	cites ClinicalTrials.gov:NCT07370922; registry reference DERIVED:42618811